Compare Futu Holdings Ltd (FUTU) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Futu Holdings Ltd vs Medpace Holdings Inc — how do they compare? Futu Holdings Ltd trades at $106.19 (market cap $14.74B), while Medpace Holdings Inc trades at $607 (market cap $16.90B). The key difference: Futu Holdings Ltd and Medpace Holdings Inc are close in size by market cap, and Futu Holdings Ltd pays a 2.47% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| FUTU | MEDP | |
|---|---|---|
Market Cap | $14.74B | $16.90B |
Sector | Financials | Technology |
52-Week High | $199.04 | $620.59 |
52-Week Low | $89.76 | $393.42 |
Enterprise Value | $14.59B | $16.52B |
Dividend Yield | 2.47% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Futu Holdings Limited (FUTU) trades at $108.70, showing modest daily movement with a slight decline of 0.29%. The stock exhibits a bullish technical trend, supported by moving averages, while recent earnings have been mixed with two misses and one beat against expectations. Strong revenue growth and profitability margins highlight solid fundamental performance, though the company faces significant legal and regulatory scrutiny.
The outlook for FUTU is cautiously optimistic, driven by robust financial health and analyst support, but overshadowed by ongoing securities class action lawsuits alleging regulatory compliance failures. Key risks include legal liabilities and market sentiment pressure, while opportunities lie in sustained earnings growth and favorable valuation metrics.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Futu Holdings Ltd
Futu Holdings Ltd is an online broker providing one-stop online investing services. The company provides its services through its digital platform Futu NiuNiu, which includes market data, trading service, and news feed of Hong Kong, Mainland China, Singapore, and United States equity markets. It generates its revenue in the form of brokerage commission and handling charge services.
Read more on FUTU →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
